Rentschler Biopharma
At Rentschler Biopharma, we are a leading contract development and manufacturing organization (CDMO) focused exclusively on our clients’ projects. We provide process development and manufacturing services for biopharmaceuticals, complemented by consulting, project management and regulatory support.
Our reputation is built on decades of experience and a commitment to quality, making us a trusted solutions partner for biotechnology and pharmaceutical companies worldwide. A robust quality management system, a well-established operational excellence philosophy and advanced technologies help ensure product quality and productivity at every stage of development and manufacturing.
As a family-owned company with approximately 1,700 employees, we are headquartered in Laupheim, Germany, and operate a state-of-the-art manufacturing site in Milford, Massachusetts, USA. Over the years, we have supported a wide range of therapeutic modalities through development and manufacturing, regularly contributing to biopharmaceutical products that achieve regulatory approval. In 2023 alone, we contributed to nearly 25% of all FDA-approved biologics.
Our commitment extends beyond scientific and operational excellence. In 2024, we joined the United Nations Global Compact, reinforcing our focus on sustainability and responsible business practices.
Interested in joining Rentschler Biopharma? Explore current career opportunities here.
